A Digital Art Activity to Enhance Self-Disclosure and the Detection of Psycho-social Distress in Adult Cancer Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06127121

Enrollment

Registered

2023-11-13

Start date

2023-11-02

Completion date

2027-08-31

Last updated

2026-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Brief summary

To look at how a digital art activity may help cancer patients improve their ability to express their distress, symptoms, and lived experience.

Detailed description

Primary objective: * To evaluate how engaging in a digital art activity might potentially cause changes in symptom reporting, based on pre/post self-reporting on the Edmonton Symptom Assessment System (ESAS) at time T3. Secondary objectives: * To evaluate the changes in symptom reporting, based on pre/post self-reporting on ESAS at different times of the study (T1, T2). * To evaluate how a specific creative art making activity (T3), compared to an active control condition (T2; music listening) may or may not impact reporting ESAS. * To monitor potential changes in distress disclosure, based on the self-report scoring on the Distress Disclosure Index score at T0, T2 and T3.

Interventions

BEHAVIORALDigital Art Activity

* complete a symptom questionnaire * complete another activity such as listening to meditative music for 10 minutes * fill out the symptom questionnaire and engage in the digital art activity again

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

1. Age equal or greater than 18 years 2. Patients who are admitted in the hospital and have received a cancer diagnosis. 3. Suffering from solid cancer or hematological malignancy and receiving active treatment for their cancer. 4. Voluntary written consent. 5. Fluent in English or Spanish.

Exclusion criteria

1. Not being able to use a digital tablet 2. Being speech impaired or vision impaired 3. Patients who are cognitively impaired and unable to read or consent for the study 4. Pregnant women

Design outcomes

Primary

Measure	Time frame	Description
The Edmonton Symptom Assessment System, (ESAS) questionnaires	through study completion; an average 1 year.	Score Scale (0-10) 0 No symptom-10 Worst possible

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORCarlos Roldan, MD

M.D. Anderson Cancer Center

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 21, 2026